MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,342 | -36.8% | 77,657 | 0.0% | 8.78% | -33.1% |
| Q2 2023 | $17,939 | -4.7% | 77,657 | 0.0% | 13.14% | -12.2% |
| Q1 2023 | $18,814 | -16.5% | 77,657 | 0.0% | 14.97% | -11.7% |
| Q4 2022 | $22,540 | -99.6% | 77,657 | 0.0% | 16.95% | +412.3% |
| Q3 2022 | $5,047,000 | -9.2% | 77,657 | 0.0% | 3.31% | -14.0% |
| Q2 2022 | $5,559,000 | -27.0% | 77,657 | 0.0% | 3.85% | +38.5% |
| Q1 2022 | $7,620,000 | +15.8% | 77,657 | 0.0% | 2.78% | +38.2% |
| Q4 2021 | $6,581,000 | +60.5% | 77,657 | +51.1% | 2.01% | +84.0% |
| Q3 2021 | $4,101,000 | -18.1% | 51,396 | 0.0% | 1.09% | -4.9% |
| Q2 2021 | $5,007,000 | -16.7% | 51,396 | 0.0% | 1.15% | -33.8% |
| Q1 2021 | $6,012,000 | +5.2% | 51,396 | 0.0% | 1.74% | +23.6% |
| Q4 2020 | $5,714,000 | -6.4% | 51,396 | 0.0% | 1.40% | -28.6% |
| Q3 2020 | $6,103,000 | – | 51,396 | – | 1.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |